Prosus Invests €400M in AI Healthcare Platform Alan at €5.5B Valuation

According to Prosus, the company today announced a €400 million investment into Alan, the European health and insurance tech leader, valuing it at €5.5 billion (US$6.3 billion). The investment includes both primary and secondary equity, with existing investors Teachers' Venture Growth (TVG) and Index Ventures, and new investor Dara Holdings joining the round.

Alan reported more than €800 million in Annual Recurring Revenue as of Q1 2026, up 53% year-on-year, and is profitable in France, its largest market. The platform serves more than 1.1 million individuals and demonstrates operating leverage through its AI-led model.